Surgical Innovations reports H1 revenue of GBP 6.019 million
For the half year ended Sep 30, Surgical Innovations said adjusted EBITDA was GBP 33,000, gross profit GBP 1.748 million and EBIT GBP -230,000.
For the half year ended Sep 30, Surgical Innovations said adjusted EBITDA was GBP 33,000, gross profit GBP 1.748 million and EBIT GBP -230,000.